» Articles » PMID: 31664501

Epidemiology of Intra-abdominal Infection and Sepsis in Critically Ill Patients: "AbSeS", a Multinational Observational Cohort Study and ESICM Trials Group Project

Abstract

Purpose: To describe the epidemiology of intra-abdominal infection in an international cohort of ICU patients according to a new system that classifies cases according to setting of infection acquisition (community-acquired, early onset hospital-acquired, and late-onset hospital-acquired), anatomical disruption (absent or present with localized or diffuse peritonitis), and severity of disease expression (infection, sepsis, and septic shock).

Methods: We performed a multicenter (n = 309), observational, epidemiological study including adult ICU patients diagnosed with intra-abdominal infection. Risk factors for mortality were assessed by logistic regression analysis.

Results: The cohort included 2621 patients. Setting of infection acquisition was community-acquired in 31.6%, early onset hospital-acquired in 25%, and late-onset hospital-acquired in 43.4% of patients. Overall prevalence of antimicrobial resistance was 26.3% and difficult-to-treat resistant Gram-negative bacteria 4.3%, with great variation according to geographic region. No difference in prevalence of antimicrobial resistance was observed according to setting of infection acquisition. Overall mortality was 29.1%. Independent risk factors for mortality included late-onset hospital-acquired infection, diffuse peritonitis, sepsis, septic shock, older age, malnutrition, liver failure, congestive heart failure, antimicrobial resistance (either methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, extended-spectrum beta-lactamase-producing Gram-negative bacteria, or carbapenem-resistant Gram-negative bacteria) and source control failure evidenced by either the need for surgical revision or persistent inflammation.

Conclusion: This multinational, heterogeneous cohort of ICU patients with intra-abdominal infection revealed that setting of infection acquisition, anatomical disruption, and severity of disease expression are disease-specific phenotypic characteristics associated with outcome, irrespective of the type of infection. Antimicrobial resistance is equally common in community-acquired as in hospital-acquired infection.

Citing Articles

Intraoperative Low-Dose Glucocorticoids in Surgical Patients With Abdominal Sepsis: A Multicenter Retrospective Cohort Study.

Tao T, Shi Y, Ye X, Mi W, Lou J Health Sci Rep. 2025; 8(2):e70360.

PMID: 39980824 PMC: 11839392. DOI: 10.1002/hsr2.70360.


Profile of Serum Inflammatory Biomarkers in Children with Peritonitis and their Role in Predicting the Severity and Outcome.

Vibhash C, Choudhury S, Maheshwari A, Sarin Y, Sharma S, Singh R J Indian Assoc Pediatr Surg. 2025; 30(1):28-35.

PMID: 39968249 PMC: 11832104. DOI: 10.4103/jiaps.jiaps_140_24.


Modified National Early Warning Scores (MNEWS) for Predicting the Outcomes of Suspected Sepsis Patients; A Prospective Cohort Study.

Diskumpon N, Ularnkul B, Srivilaithon W, Phungoen P, Daorattanachai K Arch Acad Emerg Med. 2025; 13(1):e24.

PMID: 39958963 PMC: 11829233. DOI: 10.22037/aaemj.v13i1.2407.


Antibacterial and antifungal drug concentrations in intra-abdominal abscesses: a prospective clinical study.

Cancela Costa A, Grass F, Andres Cano I, Desgranges F, Delabays C, Kritikos A Antimicrob Agents Chemother. 2024; 69(1):e0117824.

PMID: 39636126 PMC: 11784227. DOI: 10.1128/aac.01178-24.


A nomogram prediction model for the risk of intra-abdominal infection after endoscopic full-thick resection of gastric submucosal tumors.

Wang L, Huang W, Zhao J Heliyon. 2024; 10(21):e38362.

PMID: 39512459 PMC: 11539246. DOI: 10.1016/j.heliyon.2024.e38362.


References
1.
Blot S, De Waele J . Critical issues in the clinical management of complicated intra-abdominal infections. Drugs. 2005; 65(12):1611-20. DOI: 10.2165/00003495-200565120-00002. View

2.
Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View

3.
Blot S, De Waele J, Vogelaers D . Essentials for selecting antimicrobial therapy for intra-abdominal infections. Drugs. 2012; 72(6):e17-32. PMC: 3585770. DOI: 10.2165/11599800-000000000-00000. View

4.
van de Groep K, Verhoeff T, Verboom D, Bos L, Schultz M, Bonten M . Epidemiology and outcomes of source control procedures in critically ill patients with intra-abdominal infection. J Crit Care. 2019; 52:258-264. DOI: 10.1016/j.jcrc.2019.02.029. View

5.
Trouillet J, Chastre J, Vuagnat A, Joly-Guillou M, Combaux D, Dombret M . Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med. 1998; 157(2):531-9. DOI: 10.1164/ajrccm.157.2.9705064. View